REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 26 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,760 | -70.8% | 12,050,000 | -66.1% | 0.02% | -71.9% |
| Q1 2023 | $43,718 | +63.3% | 35,500,000 | +22.4% | 0.06% | +54.1% |
| Q4 2022 | $26,767 | -99.9% | 29,000,000 | -11.1% | 0.04% | -28.8% |
| Q3 2022 | $35,563,000 | +60.3% | 32,627,000 | +19.6% | 0.05% | +73.3% |
| Q2 2022 | $22,190,000 | -15.0% | 27,270,000 | -1.8% | 0.03% | 0.0% |
| Q1 2022 | $26,121,000 | -6.2% | 27,770,000 | -12.0% | 0.03% | 0.0% |
| Q4 2021 | $27,858,000 | -5.3% | 31,545,000 | +23.7% | 0.03% | -9.1% |
| Q3 2021 | $29,411,000 | +25.5% | 25,500,000 | +27.5% | 0.03% | +26.9% |
| Q2 2021 | $23,433,000 | +15.5% | 20,000,000 | +11.0% | 0.03% | +4.0% |
| Q1 2021 | $20,283,000 | – | 18,019,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |